Lung Cancer, Conjugates Emerge As Key Asia Company Themes

Among Asia Pacific pharma companies presenting new clinical data on their oncology pipelines at ASCO, lung and urothelial cancer and antibody-drug conjugates emerge as stand-out themes.

ASCO
Emerging Asia Research Themes At ASCO • Source: Alex Shimmings

Multiple Asia-based pharma companies are releasing new clinical data on pipeline oncology assets at the American Society of Clinical Oncology meeting in Chicago, and non-small cell lung cancer (NSCLC) and antibody-drug conjugates (ADCs) are emerging as early themes.

The presentations included some significant results in high-need settings and novel targets.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from ASCO

More from Conferences